Arcadia Biosciences, Inc.
- Market Cap (Float-Adj) (Float-adjusted market cap computed by the low-float screener — matches the screener row. May differ from the standard cap (price × all shares outstanding) reported elsewhere.)
- $964.3K
- Price
- $0.442
- % Change (Daily % change from the live per-ticker quote feed.)
- +4.99%
- Volume
- 70.6K
About
Arcadia Biosciences, Inc. is a U.S.-based company that provides plant-derived health and well-being products. Additionally, it is actively engaged in agricultural research and development, with a particular focus on improving wheat crops. The aim of these innovations is to enhance farmers' economic stability by boosting crop performance in the field, increasing their value for food and wellness applications, and expanding their potential for industrial uses. Established in 2002, the company's main office is located in Davis, California.
Quick stats
Shares outstanding2.2M
Computed float2.0M
Float / shares90.1%
Cash runway (months)10.5
Key info
SectorBasic Materials
IndustryAgricultural Inputs
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0001469443
Websitehttps://www.arcadiabio.com
AI Summary
AI-generated1/8
standardmixedearnings
Arcadia Biosciences (RKDA) Announces Second Quarter and First Half 2026 Financial Results and Business Highlights
Arcadia Biosciences reported Q2 revenue of $1.44 million, roughly flat year-over-year, but highlighted a dramatic reduction in cash burn to just $319,000.
The company closed a $4 million private placement in June, ending the quarter with $4.2 million in cash to fund growth.
Management stated Zola has reached an inflection point with July sales topping $740,000 and exceeding $1 million in the first week of August.
Red flags
- Net loss of $6.3M driven by $5.4M valuation loss on PIPE financing
- Going concern risk explicitly acknowledged in Safe Harbor statement requiring additional funding